Corporate Corruption News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on corporate corruption from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

A.B. "Buzzy" Krongard, a ... former investment banker ... was named yesterday executive director of the CIA, bringing a fast-paced management style to the agency's No. 3 job. Central Intelligence Agency Director George J. Tenet announced the appointment, saying he treasures Krongard's "wise counsel and 'no-nonsense' business-like views." Krongard, 64, former head of Alex. Brown & Co., an investment bank based in Baltimore, joined the agency three years ago as a counselor to Tenet. He switched careers shortly after helping engineer the $2.5 billion merger of Alex. Brown and Bankers Trust New York Corp., gaining $71 million in Bankers Trust stock. Few of his former colleagues were surprised by his decision to trade a $4 million salary and stock options for the far less remunerative job of Tenet's consigliere. A graduate of Princeton and the University of Maryland Law School, Krongard has a fondness for extreme military-style activities. Even as a banking executive, he trained with police SWAT teams for recreation and worked out with a kung fu master. He maintained a shooting range on the park-like grounds of his home on the northern edge of Baltimore. In an interview yesterday, Krongard described his past duties as those of a "minister without portfolio" whom senior managers felt comfortable talking to about "sticky subjects." But Krongard exhibited the requisite secretiveness when asked to explain his interest in intelligence and how he came to land a job in Tenet's inner circle. If you go back to the CIA's origins during World War II in the Office of Strategic Services, he explained, "the whole OSS was really nothing but Wall Street bankers and lawyers."

Note: Buzzy Krongard was the executive director of the CIA on 9/11. His past ties to the investment firm which placed most of the extraordinarily high volume of "put options" on United and American Airlines stocks the week before the attacks is one of many strange "coincidences" unexplained by the official story of what happened on that horrific day. For more on this, click here. To read the entire article free of charge, click here.

So this is how it works. A tiny, shoe-string central office in Holland decides each year which country will host the next meeting. Each country has two steering committee members. They call up Bilderberg-friendly global corporations, such as Xerox or Heinz or Fiat or Barclays or Nokia, which donate the hundreds of thousands of pounds needed. They do not accept unsolicited donations from non-Bilderberg corporations. Nobody can buy their way into a Bilderberg meeting, although many corporations have tried. Then they decide who to invite - who seems to be a "Bilderberg person". The notion of a Bilderberg person hasn't changed since the earliest days, back in 1954. The guests are expressly asked not to give interviews to journalists. There are two morning sessions and two afternoon sessions. While furiously denying that they secretly ruled the world, my Bilderberg interviewees did admit to me that international affairs had, from time to time, been influenced by these sessions. This is how Denis Healey described a Bilderberg person to me: "To say we were striving for a one-world government is exaggerated, but not wholly unfair. Bilderberg is a way of bringing together politicians, industrialists, financiers and journalists. Politics should involve people who aren't politicians."

Note: For lots more on the highly secretive Bilderberg meeting from two later BBC News article, click here. For many other revealing articles from major media reports on secret societies and secret meetings of the most rich and powerful people in our world, click here.

By next year, half of Medicare beneficiaries will have a private Medicare Advantage plan. Most large insurers in the program have been accused in court of fraud. The health system Kaiser Permanente called doctors in during lunch and after work and urged them to add additional illnesses to the medical records of patients they hadn't seen in weeks. Doctors who found enough new diagnoses could earn bottles of Champagne, or a bonus in their paycheck. Anthem, a large insurer now called Elevance Health, paid more to doctors who said their patients were sicker. And executives at UnitedHealth Group, the country's largest insurer, told their workers to mine old medical records for more illnesses. Each of the strategies – which were described by the Justice Department in lawsuits against the companies – led to diagnoses of serious diseases that might have never existed. But the diagnoses had a lucrative side effect: They let the insurers collect more money from the federal government's Medicare Advantage program. A New York Times review of dozens of fraud lawsuits, inspector general audits and investigations by watchdogs shows how major health insurers exploited the program to inflate their profits by billions of dollars. Eight of the 10 biggest Medicare Advantage insurers – representing more than two-thirds of the market – have submitted inflated bills, according to the federal audits. And four of the five largest players – UnitedHealth, Humana, Elevance and Kaiser – have faced federal lawsuits alleging ... fraud.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

In 2018, senior executives at one of the country's largest nonprofit hospital chains, Providence, were frustrated. They were spending hundreds of millions of dollars providing free health care to patients. It was eating into their bottom line. The executives, led by Providence's chief financial officer at the time, devised a solution: a program called Rev-Up. Rev-Up provided Providence's employees with a detailed playbook for wringing money out of patients – even those who were supposed to receive free care because of their low incomes, a New York Times investigation found. If patients did not pay, Providence sent debt collectors to pursue them. More than half the nation's roughly 5,000 hospitals are nonprofits like Providence. They enjoy lucrative tax exemptions; Providence avoids more than $1 billion a year in taxes. In exchange, the Internal Revenue Service requires them to provide services, such as free care for the poor, that benefit the communities in which they operate. But in recent decades, many of the hospitals have become virtually indistinguishable from for-profit companies, adopting an unrelenting focus on the bottom line and straying from their traditional charitable missions. And, as Providence illustrates, some hospital systems have not only reduced their emphasis on providing free care to the poor but also developed elaborate systems to convert needy patients into sources of revenue. The result ... is that thousands of poor patients were saddled with debts that they never should have owed.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption and health from reliable major media sources.

Jeff Smith, a partner with the influential consulting firm McKinsey & Company, accepted a highly sensitive assignment in December 2017. The opioid manufacturer Purdue Pharma ... sought out Dr. Smith. His team reviewed business plans and evaluated new drugs that Purdue hoped would help move the company beyond the turmoil associated with OxyContin, its addictive painkiller that medical experts say helped to spark the opioid epidemic. But the corporate reorganization was not Dr. Smith's only assignment. He was also helping the Food and Drug Administration overhaul its office that approves new drugs – the same office that would determine the regulatory fate of Purdue's new line of proposed products. A review ... of internal McKinsey documents found that the firm repeatedly allowed employees who served pharmaceutical companies, including opioid makers, to also consult for the F.D.A., the drug industry's primary government regulator. And, the documents show, McKinsey touted that inside access in pitches to private clients. In an email in 2014 to Purdue's chief executive, a McKinsey consultant highlighted the firm's work for the F.D.A. and stressed "who we know and what we know." McKinsey also allowed employees advising Purdue to help shape materials that were intended for government officials and agencies, including a memo in 2018 prepared for Alex M. Azar II. References to the severity of the opioid crisis in a draft version of the memo ... were cut before it was sent to Mr. Azar.

Note: For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in the pharmaceutical industry from reliable major media sources.

Pfizer made nearly $37bn (Ł27bn) in sales from its Covid-19 vaccine last year – making it one of the most lucrative products in history – and has forecast another bumper year in 2022, with a big boost coming from its Covid-19 pill Paxlovid. The US drugmaker's overall revenues in 2021 doubled to $81.3bn. The bumper sales prompted accusations from campaigners of "pandemic profiteering". The group Global Justice Now said the annual revenue of $81bn was more than the GDP of most countries. Pharmaceutical companies have been accused of not sharing the recipe for their vaccines, which would enable drugmakers in poorer countries to produce cheaper versions of them. Global Justice Now pointed out that Pfizer's Covid-19 jab was invented by BioNTech, supported by â‚Ź100m (Ł84m) in debt financing from the publicly owned European Investment Bank and a â‚Ź375m grant from the German government. Tim Bierley, a pharma campaigner at the group, said: "The development of mRNA vaccines should have revolutionised the global Covid response. "But we've let Pfizer withhold this essential medical innovation from much of the world, all while ripping off public health systems." According to Reuters, Pfizer has sold the vaccine to African countries at $3 to $10 a shot. It has indicated that a non-profit dose costs just $6.75, or Ł4.98, to produce, but it has reportedly charged the NHS Ł18 a dose for the first 100m jabs bought and Ł22 a dose for the next 89m, totalling Ł3.76bn ... amounting to an eye-watering 299% mark-up.

Note: If big Pharma really cared about public healthy, don't you think they'd be willing to sacrifice some of their huge profits and charge much less for their injections? Unfortunately, it's the old story of the rich get richer and the rest are left behind. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma profiteering from reliable major media sources.

The chief executives of America's largest airlines warned of a "catastrophic disruption" to travel and shipping operations if telecommunication companies roll out their 5G technology as planned Wednesday without limiting the technology near U.S. airports. On Tuesday, AT&T and Verizon both confirmed to CBS News that they have voluntarily agreed to postpone turning on a limited amount of towers around certain airports. "We are frustrated by the FAA's inability to do what nearly 40 countries have done, which is to safely deploy 5G technology without disrupting aviation services, and we urge it to do so in a timely manner," an AT&T spokesperson said in a statement, reiterating that the rest of their 5G launch will continue as planned. The executives, writing to Transportation Secretary Pete Buttigieg and other U.S. government officials, highlighted the risk of "economic calamity" should Verizon and AT&T proceed with deploying the new technology before the necessary upgrades and changes have been made to aviation equipment. "We are writing with urgency to request that 5G be implemented everywhere in the country except within the approximate two miles of airport runways as defined by the FAA on January 19, 2022," the CEOs said in a Monday letter. "To be blunt, the nation's commerce will grind to a halt," they said. The letter was signed by CEOs of major airlines including American, United, Delta and Southwest, as well as the leaders of shipping giants FedEx and UPS.

Note: For powerful evidence there are serious risks to human health with 5g technology, see these major media articles. The former chief of Microsoft Canada has issued an urgent warning on this.

To ward off accusations that it helps terrorists spread propaganda, Facebook has for many years barred users from speaking freely about people and groups it says promote violence. The restrictions appear to trace back to 2012, when ... Facebook added to its Community Standards a ban on "organizations with a record of terrorist or violent criminal activity." This modest rule has since ballooned into what's known as the Dangerous Individuals and Organizations policy, a sweeping set of restrictions on what Facebook's nearly 3 billion users can say about an enormous and ever-growing roster of entities deemed beyond the pale. But as with other attempts to limit personal freedoms in the name of counterterrorism, Facebook's DIO policy has become an unaccountable system that disproportionately punishes certain communities, critics say. It is built atop a blacklist of over 4,000 people and groups, including politicians, writers, charities, hospitals, hundreds of music acts, and long-dead historical figures. A range of legal scholars and civil libertarians have called on the company to publish the list so that users know when they are in danger of having a post deleted or their account suspended for praising someone on it. The company has repeatedly refused to do so, claiming it would endanger employees and permit banned entities to circumvent the policy. The Intercept has reviewed a snapshot of the full DIO list and is today publishing a reproduction of the material in its entirety.

Note: Facebook was found to be the number one platform for political disinformation campaigns in 2019. For more along these lines, see concise summaries of deeply revealing news articles on media corruption from reliable sources.

The American Medical Association's new training on pain management arrived in the midst of a burgeoning crisis. It was September 2007, and doctors were prescribing enough opioid painkillers each year for every American adult to have a bottle of the addictive pills. Overdoses were at a historic high and showed no signs of slowing down. Just four months earlier, executives at Purdue Pharma had pleaded guilty to felony charges for misleading regulators and physicians about the dangers of OxyContin. In light of this news, one might have expected the AMA ... to bring attention to the crisis in its newly updated continuing education course on how to treat pain. Instead, the 12-module training suggested that doctors were still too tentative about prescribing narcotics. "The effectiveness of opioid therapy may be undermined by misconceptions about their risks, particularly risks associated with abuse and addiction," read materials from one session. Down in the fine print, the AMA-branded course materials reveal that the training's development and distribution was made possible by an educational grant from Purdue Pharma. By now, the story of how Purdue Pharma sowed the seeds for the overdose crisis is the stuff of history books. But the years of Purdue's involvement with the AMA have been strangely absent from that narrative. Between 2002 and 2018, the AMA and the organization's philanthropic arm, the AMA Foundation, received more than $3 million from Purdue Pharma.

Note: For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption and health from reliable major media sources.

Billions of dollars in Covid aid cushioned financial losses caused by the pandemic at some of the nation's largest hospital chains. But those bailouts also helped sustain the big chains' spending sprees as they expanded even more by scooping up weakened competitors and doctors' practices. More consolidation by several major hospital systems enhanced their market prowess in many regions of the United States, even as rural hospitals and underserved communities were overwhelmed with Covid patients and struggled to stay afloat. The buying spree is likely to prompt further debate and scrutiny of the Provider Relief Fund, a package of $178 billion in congressional aid that drew sharp criticism early on for allocating so much to the wealthiest hospital systems, and that had no limits on mergers and acquisitions. "It was not the intent to be a capital infusion to the largest and most financially stable providers to allow them to simply grow their slice of market share," said Representative Katie Porter. Major employers had warned Congress that bailouts to the health care industry could spur even more consolidation and lead to price-gouging in medical care. Some of the nation's most powerful hospital chains, experts cautioned, would take advantage of the crisis, resulting in even higher prices for medical care. The big well-resourced hospitals had, frankly, a banner year, and they are now in a position to swallow up these smaller, more vulnerable groups.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

Covid-19 vaccines have created at least nine new billionaires after shares in companies producing the shots soared. Topping the list of new billionaires are Moderna CEO Stéphane Bancel and Ugur Sahin, the CEO of BioNTech, which has produced a vaccine with Pfizer (PFE). Both CEOs are now worth around $4 billion, according to an analysis by the People's Vaccine Alliance, a campaign group that includes Oxfam, UNAIDS, Global Justice Now and Amnesty International. Senior executives from China's CanSino Biologics and early investors in Moderna have also become billionaires on paper as shares skyrocketed, partly in expectation of profits earned from Covid vaccines, which also bode well for the companies' future prospects. Moderna's share price has gained more than 700% since February 2020, while BioNTech has surged 600%. CanSino Biologics' stock is up about 440% over the same period. The company's single-dose Covid-19 vaccine was approved for use in China in February. Activists said the wealth generation highlighted the stark inequality that has resulted from the pandemic. The nine new billionaires are worth a combined $19.3 billion. According to the World Health Organization, 87% of vaccine doses have gone to high- or upper middle-income countries, while low income countries have received just 0.2%. In a paper published Friday, IMF chief economist Gita Gopinath said that vaccinating 60% of the global population by mid-2022 would cost just $50 billion.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines and income inequality from reliable major media sources.

The drug that buoyed expectations for a coronavirus treatment and drew international attention for Gilead Sciences, remdesivir, started as a reject. To make progress, Gilead needed help from U.S. taxpayers. Lots of help. Three federal health agencies were deeply involved in remdesivir’s development every step of the way, providing tens of millions of dollars of government research support. Federal agencies have not asserted patent rights to Gilead’s drug. That means Gilead will have few constraints other than political pressure when it sets a price. “Without direct public investment and tax subsidies, this drug would apparently have remained in the scrapheap of unsuccessful drugs,” Rep. Lloyd Doggett (D-Tex.) ... said earlier this month. Doggett and Rep. Rosa L. DeLauro (D-Conn.) have asked Health and Human Services Secretary Alex Azar for a detailed financial accounting of federal support for remdesivir’s discovery and development. Watchdog groups ... have documented the large taxpayer-funded contributions toward the drug. Public Citizen estimates public investment at a minimum of $70 million. An independent organization that measures the cost-effectiveness of drugs said Gilead could be justified in charging up to $4,500 for a 10-day course of treatment for a single coronavirus patient. But advocates, citing a study by academic researchers on what it costs to make the drug, have said Gilead could break even by charging $1 per dose.

Note: According to this CNBC article Gilead is charging from $2,000 to $3,120 per patient despite huge subsidies. Gilead is the same company which developed Tamiflu and licensed it to Roche. Aggressive sales of Tamiflu to governments around the world brought profits of over $1 billion yet almost none of the doses sold were ever used, as described in this Reuters article. The study that is being used to tout Remdesivir was conducted by none other than Gilead. Could there be conflict of interest here? For more, see summaries of revealing news articles on big Pharma corruption.

The first trial against a pharmaceutical opioid manufacturer started Tuesday in Oklahoma in what could be a precedent-setting case for hundreds of other claims around the country. The state's attorney general, Mike Hunter, began the day by accusing Johnson & Johnson of putting profits over responsibility and argued that the company was responsible for the "worst man-made public health crisis in the history of our state and country." In the multibillion-dollar lawsuit against the drugmaker, lawyers for the state argued that Johnson & Johnson knew about the addictive nature of opioids, but misled doctors by downplaying the risks of the drugs while touting its benefits. Brad Beckworth, a lawyer for Oklahoma, argued that Johnson & Johnson was motivated to increase sales on multiple fronts as both the manufacturer of the drugs Duragesic and Nucynta and as a supplier of the raw materials for other opioid manufacturers. He argued that a marketing push by Johnson & Johnson lead doctors to overprescribe opioids in Oklahoma. If you oversupply, people will die, Beckworth repeatedly said in his opening statement while showing email communications from Johnson & Johnson sales representatives. Oklahoma settled with two other drug manufacturers before Tuesdays opening statements. In March, Purdue Pharma settled for $270 million, and on Sunday, Teva Pharmaceuticals settled for $85 million, leaving Johnson & Johnson as the sole defendants in what could a monthslong bench trial.

Note: Many doctors also profited from excessive prescribing of dangerous opioids. And according to a former DEA agent, Congress helped drug companies fuel the opioid epidemic. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.

A plot of Wall Street interests to overthrow President Roosevelt and establish a Fascist dictatorship, backed by a private army of 500,000 ex-soldiers and others, was charged by Major Gen. Smedley D. Butler, retired Marine Corps officer, who appeared yesterday before the House of Representatives Committee on Un-American Activities, which began hearings on the charges. [The committee] heard testimony from General Butler and Gerald P. Maguire, a bond salesman in the Stock Exchange firm of Grayson M.P. Murphy & Co., 52 Broadway, named by General Butler as having urged him to head the proposed Fascist army. There were immediate emphatic denials by the purported plotters. From Philadelephia came word that General Butler had told friends there that General Hugh S. Johnson, former NRA administrator, was scheduled for the role of dictator, and that J. P. Morgan & Co. as well as Murphy & Co. were behind the plot.

Note: General Butler, who was greatly loved by his troops, only discovered how he and his troops had been used by Wall Street bankers after retiring from the military. As a result, he wrote a seminal book titled "War is a Racket" for which you can find an excellent summary on this webpage. Explore a suppressed book on this titled "The Plot to Seize the White House." For more along these lines, see concise summaries of deeply revealing news articles on war from reliable major media sources. Then explore the excellent, reliable resources provided in our War Information Center.

The U.S. spends more on healthcare than any country in the world [yet] consistently ranks near the bottom of high-income nations for life expectancy, chronic disease burden and preventable deaths. While many drugs are lifesaving and essential, prescription medications are now recognized as the third leading cause of death in industrialized countries, behind only heart disease and cancer. Research consistently shows that up to 80% of chronic conditions, including cardiovascular disease, Type 2 diabetes and certain cancers, could be prevented or significantly reduced through natural health approaches such as nutrition, lifestyle change, supplements and other preventive interventions. If this is the case, why are these approaches not more central to chronic disease prevention and care? Health outcomes ... are shaped by who writes the rules, who controls the market and by whom health information is controlled. Natural health is constrained at the level of evidence, where money determines what qualifies as "science." In 1991, about 80% of industry-funded clinical trials were conducted in academic medical centers; by 2004, that figure had fallen to 26%, replaced by for-profit research organisations contracted by drug companies. This shift has untold impact: Study designs, publications, regulations and medical education reflect pharmaceutical interests, leaving natural therapies – without comparable capital – unable to produce the forms of evidence regulators, insurers and clinicians are structurally conditioned to demand. Following the Myriad case, naturally occurring substances are largely excluded from patent protection, leaving high research costs with little legal protection. Without intellectual property protection, investors see little upside, research dries up and innovation slows. Combined with regulatory capture and heavy pharmaceutical lobbying, control of money and markets systematically prioritises pharmaceutical over natural health and substances long before consumers are offered a real choice.

Note: Watch an educational presentation by WantToKnow.info director Amber Yang on the deepest challenges facing our media and public health systems today, including real world solutions that move beyond disease-care. For more along these lines, check out our Substack, Inspiring Remedies to the Chronic Illness Crisis.

New York City's public hospital system is paying millions to Palantir, the controversial ICE and military contractor. Since 2023, the New York City Health and Hospitals Corporation has paid Palantir nearly $4 million to improve its ability to track down payment for the services provided at its hospitals and medical clinics. Palantir, a data analysis firm that's now a Wall Street giant thanks to its lucrative work with the Pentagon and U.S. intelligence community, deploys its software to make more efficient the billing of Medicaid and other public benefits. That includes automated scanning of patient health notes to "increase charges captured from missed opportunities," contract materials reviewed by The Intercept show. It's Palantir's work with U.S. Immigration and Customs Enforcement that is drawing the most protest today. The company provides a variety of services to help the federal government find and deport immigrants. ICE's Palantir-furnished case management software, for example, "plays a critical role in supporting the daily operations of ICE, ensuring critical mission success," according to federal contracting documents. Palantir's contract with New York's public health care system allows the company to work with patients' protected health information, or PHI. With permission from New York City Health and Hospitals, Palantir can "de-identify PHI and utilize de-identified PHI for purposes other than research," the contract states.

Note: Listen to an audio clip of Jeffrey Epstein promoting Palantir to Ehud Barak. Read how Palantir helped the NSA spy on the entire planet. For more along these lines, read our concise summaries of news articles on Big Tech and the disappearance of privacy.

On Thursday, lawmakers in the House approved a "pilot program" in the pending Pentagon budget bill that could eventually open the door to sending billions to big contractors, while providing what critics say would be little benefit to the military. The provision, which appeared in the budget bill after a closed-door session overseen by top lawmakers, would allow contractors to claim reimbursement for the interest they pay on debt they take on to build weapons and other gadgets for the armed services. One big defense contractor alone, Lockheed Martin, reported having more than $17.8 billion in outstanding interest payments last year, said Julia Gledhill, an analyst at the nonprofit Stimson Center. "The fact that we are even exploring this question is a little crazy in terms of financial risk for the government," Gledhill said. Gledhill said even some Capitol Hill staffers were "scandalized" to see the provision in the final bill, which will likely be approved by the Senate. The switch to covering financing costs seems to be in line with a larger push this year to shake up the defense industry. The Pentagon itself was dubious in a 2023 study conducted by the Office of the Under Secretary of Defense for Acquisition and Sustainment. The Pentagon found that policy change might even supercharge the phenomenon of big defense contractors using taxpayer dollars for stock buybacks instead of research and development.

Note: Read our concise summaries of news articles on government corruption.

The idea of a "right to repair" – a requirement that companies facilitate consumers' repairs, maintenance, and modification of products – is extremely popular, even winning broad, bipartisan support in Congress. That could not, however, save it from the military–industrial complex. Lobbyists succeeded in killing part of the National Defense Authorization Act that would have given service members the right to fix their equipment in the field without having to worry about military suppliers' intellectual property. The decision to kill the popular proposal was made public Sunday after a closed-door conference of top congressional officials, including defense committee chairs. For the defense industry ... the proposal threatened a key profit stream. Once companies sell hardware and software to the Pentagon, they can keep making money by forcing the government to hire them for repairs. Defense lobbyists pushed back hard against the proposal when it arose in the military budgeting process. The CEO of the Aerospace Industries Association claimed that the legislation could "cripple the very innovation on which our warfighters rely." The contractors' argument was that inventors would not sell their products to the Pentagon if they knew they had to hand over their trade secrets as well. As a piece of legislation, the right to repair has likely died until next year's defense budget bill process. The notion could be imposed in the form of internal Pentagon policies.

Note: For more along these lines, read our concise summaries of news articles on military corruption.

The city of San Francisco filed the nation's first government lawsuit against some of the largest manufacturers of ultra-processed foods on Tuesday, asserting that the 10 corporations knew the products were harming Americans' health but continued to market them anyway. The corporations include cereal giants Kellogg, Post Holdings and General Mills, candy makers NestlĂ© USA and Mars Incorporated, the soda companies behind Coca-Cola and PepsiCo, as well as Kraft Heinz Company, ConAgra Brands and Mondelz International. The suit argues that the health care costs of treating related health conditions tied to consuming ultra-processed foods – upwards of $100 billion a year – have fallen on Americans, cities and states. "These companies created a public health crisis with the engineering and marketing of ultra-processed foods," San Francisco City Attorney David Chiu said. "They took food and made it unrecognizable and harmful to the human body." "We must be clear that this is not about consumers making better choices. Recent surveys show Americans want to avoid ultra-processed foods, but we are inundated by them. These companies engineered a public health crisis, they profited handsomely, and now they need to take responsibility for the harm they have caused," he added. Some 70 percent of the U.S. food supply is ultra-processed, according to the U.S. Food and Drug Administration.

Note: For more along these lines, read our concise summaries of news articles on health and food system corruption.

It was early 2012 when doctors found a tumor in Kim Franzi's brain. Franzi underwent a risky two-day brain surgery to remove the mass, which doctors warned could leave her paralyzed or prove fatal. The operation was successful, but more than 13 years later, she still suffers from side effects, including issues with her reflexes, teeth, hearing, and vision. Before discovering the tumor, Franzi used the birth control shot Depo-Provera for more than 15 years. The shot has been used by roughly one in four sexually active women in the United States, bringing in hundreds of millions in profits annually for the pharmaceutical behemoth Pfizer, which manufactures and distributes the drug. But according to more than 1,200 lawsuits, Pfizer has failed to properly warn the public about long-established links between Depo-Provera and meningiomas. That includes a lawsuit submitted on Franzi's behalf, plus more than 9,500 cases that have yet to be filed. In 2024, a large study of more than 18,000 cases of women undergoing surgery for meningiomas found that "prolonged use of [Depo-Provera] was found to increase the risk of intracranial meningioma." Specifically, the scientists found that use of Depo-Provera was associated with a more than five-fold heightened risk of developing a meningioma that required surgery, and that risk increased further if patients used Depo-Provera for more than a year. Drug labels for Depo-Provera in the European Union, United Kingdom, New Zealand, Australia, and Canada ... warn about these brain tumors.

Note: Read the full article to learn about how Pfizer omitted six studies that found significant links between patients taking the birth control shot and brain tumors. For more along these lines, read our concise summaries of news articles on health and Big Pharma corruption.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.